Conroy to visit US and India The Minister for Defence Industry and Minister for International Development and the Pacific Pat Conroy will travel to the United States and India this week. In the United States he will hold high-level talks with representatives from the US Administration and Congress to advance the implementation of the pathway…
Micro-X wins international design award X-ray company Micro-X has won an internationally-renowned iF Design Award for its Argus X-ray Camera. According to a statement from the Adelaide-based company, Argus won over the 133-member jury, made up of independent experts from all over the world, for its high impact in transforming stand-off imaging capability for bomb…
Apprentice numbers on the rise The latest data from the National Centre for Vocational Education Research (NCVER) show there were 402,245 apprentices and trainees in-training as at 30 September 2022, 14 per cent higher than at the same time in 2021. The figures, in the report Apprentices and trainees 2022: September quarter, also show apprentice…
H2X Global partners with Norwegian Hydrogen Australian-headquartered hydrogen fuel cell vehicle manufacturer H2X Global announced the signing of a memorandum of understanding (MoU) last week with Norwegian Hydrogen, a green hydrogen production, distribution and refueling company. according to a statement from the pair, it will cover collaboration on commercial supply of hydrogen and a range…
CSIRO has opened a new $23.1 million national laboratory in Melbourne that will bolster the nation’s ability to produce vaccines and drug treatments onshore. Researchers at CSIRO’s National Vaccine and Therapeutics Lab will turn vaccine and drug candidates into products that can be manufactured in quantity for clinical trials. According to a statement from CSIRO,…
Clinical trials begin for Australian developed Covid-19 vaccines Clinical human trials have begun on subjects in Melbourne to test the effectiveness and safety of two Melbourne-developed Covid-19 vaccines. The traditional protein-based vaccine was developed by the Doherty Institute, while a mRNA vaccine was developed by Monash Institute of Pharmaceutical Sciences. Melbourne’s IDT Australia manufactured the…
IDT misses out on MMI grant for mRNA vaccines Drug manufacturer IDT Australia has missed out on a Modern Manufacturing Initiative collaboration stream grant from the federal government to further development of mRNA vaccine manufacturing capabilities. The company, which is manufacturing the vaccine components for clinical trials of a mRNA vaccine developed by Monash University,…
IDT Australia’s strong year as it develops mRNA technologies Independent pharmaceutical manufacturer IDT Australia has reported revenues up 74 per cent in the first half FY 22 to $8.56 million as its developed its capabilities in sterile manufacturing. Profit after tax was $1.21 million, up slightly from $1.12 million in the previous corresponding period. During…
By Peter Roberts Prime Minister Scott Morrison announced today that state and federal governments and vaccine producer Moderna had signed an ‘in principle’ deal for the construction of a Melbourne plant capable of utilising the newly successful vaccine production technologies that produced the Pfizer and Moderna vaccines. The plant would be capable of producing up…
By Peter Roberts It turns out those hippies who dropped out to Nimbin in the 1960s and 70s really were on to something. Their pioneering work as guinea pigs living on wisps of pot and mung beans is rapidly turning into a major industry in growing, processing and manufacture of medicinal cannabis products. Although Australia…
